Drug intelligence / Profile preview

bupivacaine + epinephrine + clonidine + dexamethasone

Development stage
Unknown
Lead developer
Regionshospitalet Silkeborg
Modality
Small Molecules
Administration
Perineural
01

Overview

This multimodal analgesic combination, often referred to as a 'protracted mixture,' consists of the local anesthetic bupivacaine (Marcaine), the vasoconstrictor epinephrine (adrenaline), the alpha-2 adrenergic agonist clonidine, and the synthetic corticosteroid dexamethasone. It was specifically evaluated in a Phase 4 randomized clinical trial (Hobsali) conducted by Regionshospitalet Silkeborg for the management of postoperative pain following total knee arthroplasty. In this context, dexamethasone acts as a glucocorticoid adjuvant that prolongs the duration of sensory nerve blocks and reduces systemic inflammatory responses. The combination is administered via saphenous and obturator nerve blocks to provide extended analgesia, reduce postoperative opioid consumption, and minimize associated side effects such as nausea and vomiting.

Other names
dexamethasone-Regionshospitalet Silkeborg-postoperative painprotracted mixtureHobsali mixture
02

Targets

ADRA2A (α2A)NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)ADRA1A (α1A)β-AR (Beta-adrenergic receptor family)ADRB1 (β1)

Beyond the preview

Go deeper on bupivacaine + epinephrine + clonidine + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + epinephrine + clonidine + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call